The Concept of Divergent Targeting through the Activation and Inhibition of Receptors as a Novel Chemotherapeutic Strategy: Signaling Responses to Strong DNA-Reactive Combinatorial Mimicries

<table>Chemical structures of Iressa, mechlorethamine (HN2), binary ErbB1-DNA damage combi-molecules (ZRBA4 and ZR2003), and octreotide (OCT).</table>

Journal of Signal Transduction

fig1

Figure 1

Figure 1: The Concept of Divergent Targeting through the Activation and Inhibition of Receptors as a Novel Chemotherapeutic Strategy: Signaling Responses to Strong DNA-Reactive Combinatorial Mimicries 

Figure 1 | The Concept of Divergent Targeting through the Activation and Inhibition of Receptors as a Novel Chemotherapeutic Strategy: Signaling Responses to Strong DNA-Reactive Combinatorial Mimicries 